Skip to Main Content
Table 1

HLA type of patients enrolled in study

HLA-A, -B, and -DR were determined on aliquots of PBMCs at the time of entry into the study.
PatientHLA-AHLA-BHLA-DR
VC9421 24,26 14,45 NDa 
LR3530 3,11 
KK8169 3,24 35,51 ND* 
CZ8474 24 49,62 11,13 
TS5437 1,28 37,62 4,10 
ER9519 3,29 35,44 1,7 
DG4965 1,23 1,10 
CC7062 1,2 27 1,11 
HLA-A, -B, and -DR were determined on aliquots of PBMCs at the time of entry into the study.
PatientHLA-AHLA-BHLA-DR
VC9421 24,26 14,45 NDa 
LR3530 3,11 
KK8169 3,24 35,51 ND* 
CZ8474 24 49,62 11,13 
TS5437 1,28 37,62 4,10 
ER9519 3,29 35,44 1,7 
DG4965 1,23 1,10 
CC7062 1,2 27 1,11 
a

ND, not determined. Inadequate number of lymphocytes available.

Close Modal

or Create an Account

Close Modal
Close Modal